{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:52:17Z","timestamp":1789908737687,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T00:00:00Z","timestamp":1555718400000},"content-version":"am","delay-in-days":262,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["U19 AI109946"],"award-info":[{"award-number":["U19 AI109946"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.coi.2018.04.001","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T04:13:12Z","timestamp":1524197592000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Development of next generation hemagglutinin-based broadly protective influenza virus vaccines"],"prefix":"10.1016","volume":"53","author":[{"given":"Raffael","family":"Nachbagauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2018.04.001_bib0270","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijid.2007.11.003","article-title":"Insights into infectious disease in the era of Hippocrates","volume":"12","author":"Pappas","year":"2008","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.coi.2018.04.001_bib0275","series-title":"Influenza (Seasonal) Fact Sheet 211","author":"WHO","year":"2018"},{"key":"10.1016\/j.coi.2018.04.001_bib0280","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.001_bib0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918\u20131920 \u201cSpanish\u201d influenza pandemic","volume":"76","author":"Johnson","year":"2002","journal-title":"Bull Hist Med"},{"key":"10.1016\/j.coi.2018.04.001_bib0290","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2018.04.001_bib0295","series-title":"2015-06-21 03:35:48 2015. WHO | Pandemic (H1N1) 2009\u2014Update 67, on World Health Organization (WHO)","author":"WHO","year":"2018"},{"key":"10.1016\/j.coi.2018.04.001_bib0300","series-title":"CDC Novel H1N1 Flu | The 2009 H1N1 Pandemic: Summary Highlights","author":"CDC","year":"2016"},{"key":"10.1016\/j.coi.2018.04.001_bib0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1586\/14760584.2014.852476","article-title":"Influenza vaccines: from whole virus preparations to recombinant protein technology","volume":"13","author":"Huber","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coi.2018.04.001_bib0310","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(00)78541-2","article-title":"A virus obtained from influenza patients","volume":"2","author":"Smith","year":"1933","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2018.04.001_bib0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.92.2392.405","article-title":"A new type of virus from epidemic influenza","volume":"92","author":"Francis","year":"1940","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.04.001_bib0320","first-page":"135","article-title":"The Army experience with influenza, 1946\u20131947; epidemiological aspects","volume":"47","author":"Sartwell","year":"1948","journal-title":"Am J Hyg"},{"key":"10.1016\/j.coi.2018.04.001_bib0325","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1586\/14760584.2013.824709","article-title":"The evolving history of influenza viruses and influenza vaccines","volume":"12","author":"Hannoun","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coi.2018.04.001_bib0330","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2105\/AJPH.37.8.1013","article-title":"Experience with vaccination against influenza in the spring of 1947; a preliminary report","volume":"37","author":"Francis","year":"1947","journal-title":"Am J Public Health Nations Health"},{"key":"10.1016\/j.coi.2018.04.001_bib0335","first-page":"755","article-title":"The influenza programme of WHO","volume":"8","author":"Payne","year":"1953","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coi.2018.04.001_bib0340","series-title":"WHO Recommendations on the Composition of Influenza Virus Vaccines","author":"WHO","year":"2018"},{"key":"10.1016\/j.coi.2018.04.001_bib0345","doi-asserted-by":"crossref","first-page":"373","DOI":"10.7326\/0003-4819-89-3-373","article-title":"Influenza vaccine: preliminary statement. Recommendation of the Public Health Service Advisory Committee on Immunization Practices","volume":"89","author":"Practices PHSACoI.","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coi.2018.04.001_bib0350","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0042-6822(83)90465-8","article-title":"Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants","volume":"126","author":"Graves","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.04.001_bib0355","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/jvi.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.001_bib0360","series-title":"A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals\u2019 Investigational Supra-Seasonal Universal Influenza Vaccines\u2014Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years","author":"GlaxoSmithKline","year":"2017"},{"key":"10.1016\/j.coi.2018.04.001_bib0365","series-title":"Safety and Immunogenicity of a Live-Attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine","author":"PATH","year":"2017"},{"key":"10.1016\/j.coi.2018.04.001_bib0370","series-title":"Fields Virology","first-page":"1151","author":"Shaw","year":"2013"},{"key":"10.1016\/j.coi.2018.04.001_bib0375","doi-asserted-by":"crossref","first-page":"e25797","DOI":"10.1371\/journal.pone.0025797","article-title":"H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination","volume":"6","author":"Moody","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2018.04.001_bib0380","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coi.2018.04.001_bib0385","doi-asserted-by":"crossref","DOI":"10.3390\/v8060155","article-title":"Accurate measurement of the effects of all amino-acid mutations on influenza hemagglutinin","volume":"8","author":"Doud","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2018.04.001_bib0390","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.04.001_bib0395","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1128\/JVI.00700-11","article-title":"A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin","volume":"85","author":"Krause","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.001_bib0400","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin","volume":"108","author":"Whittle","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.04.001_bib0405","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.04.001_bib0410","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.001_bib0415","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.001_bib0420","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.001_bib0425","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.001_bib0430","doi-asserted-by":"crossref","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","volume":"1","author":"Nachbagauer","year":"2016","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.coi.2018.04.001_sbref0435","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.coi.2018.04.001_bib0440","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1073\/pnas.1007465107","article-title":"Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge","volume":"107","author":"Bommakanti","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.04.001_bib0445","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.vaccine.2015.05.038","article-title":"Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses","volume":"33","author":"Wohlbold","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.001_sbref0450","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.04.001_sbref0455","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2018.04.001_bib0460","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.coi.2018.04.001_sbref0465","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41541-017-0036-2","article-title":"Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines","volume":"2","author":"Sutton","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.coi.2018.04.001_bib0470","doi-asserted-by":"crossref","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","article-title":"Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection","volume":"111","author":"Mallajosyula","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.04.001_bib0475","doi-asserted-by":"crossref","first-page":"22666","DOI":"10.1038\/srep22666","article-title":"Stalking influenza by vaccination with pre-fusion headless HA mini-stem","volume":"6","author":"Valkenburg","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2018.04.001_bib0480","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets","volume":"29","author":"Giles","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.04.001_bib0485","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/21645515.2015.1012013","article-title":"Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades","volume":"11","author":"Crevar","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coi.2018.04.001_bib0490","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/CVI.05533-11","article-title":"Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines","volume":"19","author":"Giles","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2018.04.001_bib0495","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/infdis\/jis232","article-title":"A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection","volume":"205","author":"Giles","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.04.001_sbref0500","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.03152-15","article-title":"Design and characterization of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1 influenza viruses","volume":"90","author":"Carter","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.001_bib0505","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01581-17","article-title":"Computationally optimized broadly reactive hemagglutinin elicits hemagglutination inhibition antibodies against a panel of H3N2 influenza virus cocirculating variants","volume":"91","author":"Wong","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.001_bib0510","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01283-17","article-title":"Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets preimmune to historical H1N1 influenza viruses","volume":"91","author":"Carter","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.04.001_bib0515","doi-asserted-by":"crossref","first-page":"e01044","DOI":"10.1128\/mBio.01044-15","article-title":"An intranasal virus-like particle vaccine broadly protects mice from multiple subtypes of influenza A virus","volume":"6","author":"Schwartzman","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.coi.2018.04.001_bib0520","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1073\/pnas.79.2.569","article-title":"Anti-influenza response achieved by immunization with a synthetic conjugate","volume":"79","author":"Muller","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.04.001_bib0525","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1586\/14760584.6.6.939","article-title":"Epitope-based vaccine against influenza","volume":"6","author":"Ben-Yedidia","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coi.2018.04.001_bib0530","series-title":"Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine","author":"NIAID","year":"2017"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517301929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517301929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:43:50Z","timestamp":1760604230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791517301929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":53,"alternative-id":["S0952791517301929"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2018.04.001","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of next generation hemagglutinin-based broadly protective influenza virus vaccines","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2018.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}